Get the Stockscreener App
5.13
5.34%
0.26
Abeona Therapeutics Inc stock is traded at $5.13, with a volume of 1.76M.
It is up +5.34% in the last 24 hours and up +22.14% over the past month.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$4.87
Open:
$5.09
24h Volume:
1.76M
Relative Volume:
1.08
Market Cap:
$278.00M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-1.9884
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
+7.32%
1M Performance:
+22.14%
6M Performance:
-23.89%
1Y Performance:
-14.93%
1-Day Range:
$4.93
$5.35
1-Week Range:
$4.53
$5.35
52-Week Range:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Name
Abeona Therapeutics Inc
Sector
Industry
Phone
646-813-4701
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.13 | 263.91M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.04 | 115.56B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
703.26 | 75.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.02 | 60.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
900.76 | 55.48B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
196.55 | 43.51B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Mar-05-25 | Initiated | Oppenheimer | Outperform |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| May-30-24 | Initiated | Stifel | Buy |
| Nov-11-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Feb-10-20 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Resumed | Cantor Fitzgerald | Neutral |
| Aug-15-19 | Downgrade | Maxim Group | Buy → Hold |
| Aug-12-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-26-19 | Downgrade | Mizuho | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Oct-12-18 | Initiated | Mizuho | Buy |
| Jun-05-18 | Initiated | Seaport Global Securities | Buy |
| Nov-08-17 | Initiated | SunTrust | Buy |
| Oct-16-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-11-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Oct-10-17 | Initiated | Citigroup | Buy |
| Oct-05-17 | Reiterated | Maxim Group | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Jul-18-17 | Reiterated | Maxim Group | Buy |
| Jun-22-17 | Resumed | Jefferies | Buy |
| Jan-06-17 | Initiated | Jefferies | Buy |
| Sep-29-16 | Reiterated | Maxim Group | Buy |
View All
Abeona Therapeutics Inc Stock (ABEO) Latest News
Abeona Therapeutics (ABEO) Begins First Commercial Use of ZEVASK - GuruFocus
Abeona Therapeutics Announces First Commercial Patient Treatment with FDA-Approved ZEVASKYN for Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - GlobeNewswire
Is Abeona Therapeutics Stock Built to Withstand a Pullback? - Trefis
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Abeona Therapeutics Inc. stock attractive to growth funds2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Will Abeona Therapeutics Inc. stock see PE expansionSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
How forex fluctuations impact Abeona Therapeutics Inc. (PCJ) stockMarket Growth Summary & Expert Curated Trade Ideas - Newser
How strong is Abeona Therapeutics Inc. stock balance sheetVolume Spike & Community Trade Idea Sharing - Newser
Abeona Therapeutics (ABEO) Stock Analysis Report | Financials & Insights - Benzinga
Why retail traders accumulate Abeona Therapeutics Inc. (PCJ) stockMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock sustain revenue momentumJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Published on: 2025-12-02 01:12:50 - Newser
Abeona Therapeutics (ABEO) Distributes Equity Awards to New Empl - GuruFocus
Abeona announces employee inducement grants under Nasdaq rule - marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
ABEO FY2025 EPS Forecast Lifted by Cantor Fitzgerald - MarketBeat
Why institutional investors increase stakes in Abeona Therapeutics Inc. (PCJ) stock2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
What analysts say about Abeona Therapeutics Inc stockREITs Market Trends & Small Capital Growth Stocks - earlytimes.in
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Liquidity Mapping Around (ABEO) Price Events - news.stocktradersdaily.com
Here's Why Abeona Therapeutics Popped Higher Today - MSN
What technical patterns form on Abeona Therapeutics Inc. (PCJ) stock chartsJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
How Abeona Therapeutics Inc. (PCJ) stock behaves in tightening cyclesGold Moves & Verified Momentum Stock Alerts - newser.com
Abeona Therapeutics Earnings Call: Positive Outlook Amid Challenges - MSN
Is Abeona Therapeutics Inc. (PCJ) stock positioned for digital growth eraIPO Watch & Low Risk Investment Opportunities - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock trading at attractive multiples2025 Price Momentum & Weekly High Potential Alerts - newser.com
Visualizing Abeona Therapeutics Inc. stock with heatmapsVolume Spike & Community Trade Idea Sharing - newser.com
Will Abeona Therapeutics Inc. stock benefit from green energy trendsTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Sentiment analysis tools applied to Abeona Therapeutics Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
FY2025 Earnings Estimate for ABEO Issued By HC Wainwright - MarketBeat
Is Abeona Therapeutics Inc a good long term investmentDividend Reinvestment Plans & Market-Leading Growth Rates - earlytimes.in
Is Abeona Therapeutics Inc. (PCJ) stock supported by free cash flowJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Sector ETF performance correlation with Abeona Therapeutics Inc.2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
How Abeona Therapeutics Inc. stock reacts to inflationary pressuresMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Abeona Therapeutics Inc Stock (ABEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):